Activation of human T cells obtained pre- and post-interleukin-2 (IL-2) therapy by anti-CD3 monoclonal antibody plus IL-2: implications for combined in vivo treatment.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples